Effects of a nitro compound patch on neuropathy in Churg-Strauss syndrome.
Tsurikisawa
N
N
Clinical Research Center of Sagamihara, National Hospital, Kanagawaken 228-8522 Japan. n-tsurikisawa@sagamihara.hosp.gr.jp
Taniguchi
M
M
Suzuki
S
S
Akiyama
K
K
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D015267:Churg-Strauss Syndrome / Q000188:drug therapy* / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008875:Middle Aged; D020030:Nitric Oxide Donors / Q000627:therapeutic use; D009574:Nitro Compounds / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000627:therapeutic use; D020427:Peroneal Neuropathies / Q000188:drug therapy* / Q000209:etiology*; D011657:Pulmonary Eosinophilia / Q000188:drug therapy / Q000209:etiology; D013726:Terbutaline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D007166:Immunosuppressive Agents; D020030:Nitric Oxide Donors; D009574:Nitro Compounds; D014665:Vasodilator Agents; C010809:tulobuterol; D003520:Cyclophosphamide; D013806:Theophylline; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate; D013726:Terbutaline